About
Experienced executive, project leader and researcher with a demonstrated history of…
Activity
-
📢 SpliceBio CEO and Co-Founder, Miquel Vila-Perello, is featured in Bloomberg’s latest article on how Barcelona is emerging as a key hub for biotech…
📢 SpliceBio CEO and Co-Founder, Miquel Vila-Perello, is featured in Bloomberg’s latest article on how Barcelona is emerging as a key hub for biotech…
Liked by Miquel Vila-Perello
-
It is with great pride that Atamyo announces these 2 major milestones for our ATA-100 gene therapy in LGMD-R9. Dose finding results show Atamyo’s…
It is with great pride that Atamyo announces these 2 major milestones for our ATA-100 gene therapy in LGMD-R9. Dose finding results show Atamyo’s…
Liked by Miquel Vila-Perello
-
I'm excited to join the 25th #BioEquityEurope. This year's theme: Can European biotech rise to the complexity of the moment? Visit…
I'm excited to join the 25th #BioEquityEurope. This year's theme: Can European biotech rise to the complexity of the moment? Visit…
Liked by Miquel Vila-Perello
Experience
Education
Publications
-
Structure of the branched intermediate in protein splicing
Proceedings of the National Academy of Sciences
Inteins are autoprocessing domains that cut themselves out of host proteins in a traceless manner. This process, known as protein splicing, involves multiple chemical steps that must be coordinated to ensure fidelity in the process. The committed step in splicing involves attack of a conserved Asn side-chain amide on the adjacent backbone amide, leading to an intein-succinimide product and scission of that peptide bond. This cleavage reaction is stimulated by formation of a branched…
Inteins are autoprocessing domains that cut themselves out of host proteins in a traceless manner. This process, known as protein splicing, involves multiple chemical steps that must be coordinated to ensure fidelity in the process. The committed step in splicing involves attack of a conserved Asn side-chain amide on the adjacent backbone amide, leading to an intein-succinimide product and scission of that peptide bond. This cleavage reaction is stimulated by formation of a branched intermediate in the splicing process. The mechanism by which the Asn side-chain becomes activated as a nucleophile is not understood. Here we solve the crystal structure of an intein trapped in the branched intermediate step in protein splicing. Guided by this structure, we use protein-engineering approaches to show that intein-succinimide formation is critically dependent on a backbone-to-side-chain hydrogen-bond. We propose that this interaction serves to both position the side-chain amide for attack and to activate its nitrogen as a nucleophile. Collectively, these data provide an unprecedented view of an intein poised to carry out the rate-limiting step in protein splicing, shedding light on how a nominally nonnucleophilic group, a primary amide, can become activated in a protein active site.
Other authorsSee publication -
Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells
Nature Chemical Biology
Targeted delivery of antigens to dendritic cells (DCs) is a promising vaccination strategy. However, to ensure immunity, the approach depends on coadministration of an adjuvant. Here we ask whether targeting of both adjuvant and antigen to DCs is sufficient to induce immunity. Using a protein ligation method, we develop a general approach for linking the immune stimulant, poly dA:dT (pdA:dT), to a monoclonal antibody (mAb) specific for DEC205 (DEC). We show that DEC-specific mAbs deliver pdA:dT…
Targeted delivery of antigens to dendritic cells (DCs) is a promising vaccination strategy. However, to ensure immunity, the approach depends on coadministration of an adjuvant. Here we ask whether targeting of both adjuvant and antigen to DCs is sufficient to induce immunity. Using a protein ligation method, we develop a general approach for linking the immune stimulant, poly dA:dT (pdA:dT), to a monoclonal antibody (mAb) specific for DEC205 (DEC). We show that DEC-specific mAbs deliver pdA:dT to DCs for the efficient production of type I interferon in human monocyte-derived DCs and in mice. Notably, adaptive T-cell immunity is elicited when mAbs specific for DEC-pdA:dT are used as the activation stimuli and are administered together with a DC-targeted antigen. Collectively, our studies indicate that DCs can integrate innate and adaptive immunity in vivo and suggest that dual delivery of antigen and adjuvant to DCs might be an efficient approach to vaccine development.
Other authors -
-
Streamlined expressed protein ligation using split inteins
Journal of the American Chemical Society
Chemically modified proteins are invaluable tools for studying the molecular details of biological processes, and they also hold great potential as new therapeutic agents. Several methods have been developed for the site-specific modification of proteins, one of the most widely used being expressed protein ligation (EPL) in which a recombinant α-thioester is ligated to an N-terminal Cys-containing peptide. Despite the widespread use of EPL, the generation and isolation of the required…
Chemically modified proteins are invaluable tools for studying the molecular details of biological processes, and they also hold great potential as new therapeutic agents. Several methods have been developed for the site-specific modification of proteins, one of the most widely used being expressed protein ligation (EPL) in which a recombinant α-thioester is ligated to an N-terminal Cys-containing peptide. Despite the widespread use of EPL, the generation and isolation of the required recombinant protein α-thioesters remain challenging. We describe here a new method for the preparation and purification of recombinant protein α-thioesters using engineered versions of naturally split DnaE inteins. This family of autoprocessing enzymes is closely related to the inteins currently used for protein α-thioester generation, but they feature faster kinetics and are split into two inactive polypeptides that need to associate to become active. Taking advantage of the strong affinity between the two split intein fragments, we devised a streamlined procedure for the purification and generation of protein α-thioesters from cell lysates and applied this strategy for the semisynthesis of a variety of proteins including an acetylated histone and a site-specifically modified monoclonal antibody.
Other authorsSee publication -
A Minimalist Design Approach to Antimicrobial Agents Based on a Thionin Template
Journal of Medicinal Chemistry, 2006, Vol. 49, No. 2 Published on Web 12/24/2005
Abstract: Numerous studies have been devoted to the stabilization of
secondary structure elements to improve receptor-ligand recognition.
We report a novel application of this principle to create new antimicrobial
agents using the highly folded thionin from Pyrularia pubera
as a template. Non-native disulfide bonds have been used to induce
two short linear segments of the protein into an amphipathic helix.
The resulting 13- and 9-residue peptides are significantly more…Abstract: Numerous studies have been devoted to the stabilization of
secondary structure elements to improve receptor-ligand recognition.
We report a novel application of this principle to create new antimicrobial
agents using the highly folded thionin from Pyrularia pubera
as a template. Non-native disulfide bonds have been used to induce
two short linear segments of the protein into an amphipathic helix.
The resulting 13- and 9-residue peptides are significantly more active
than their linear counterparts and have an activity similar to that of
native thionin.Other authors -
Languages
-
English
Native or bilingual proficiency
-
Spanish
Native or bilingual proficiency
-
Catalan
Native or bilingual proficiency
More activity by Miquel
-
NEWS | Asabys Partners’ investee company Augustine Therapeutics closes a Series A financing round with $85 million 👉 https://tuit.cat/C7SU0 Clara…
NEWS | Asabys Partners’ investee company Augustine Therapeutics closes a Series A financing round with $85 million 👉 https://tuit.cat/C7SU0 Clara…
Liked by Miquel Vila-Perello
-
I'm thrilled to share that I'll be speaking at the World Orphan Drug Congress USA 2025 from April 22-24! I can't wait to dive into engaging…
I'm thrilled to share that I'll be speaking at the World Orphan Drug Congress USA 2025 from April 22-24! I can't wait to dive into engaging…
Liked by Miquel Vila-Perello
-
"Spain has moved in the opposite direction and now ranks first in Europe in clinical trials, according to researcher IQVIA. Much of the activity is…
"Spain has moved in the opposite direction and now ranks first in Europe in clinical trials, according to researcher IQVIA. Much of the activity is…
Liked by Miquel Vila-Perello
-
📢 Today, in addition to announcing Stuart Hughes as our new CEO, we're also welcoming life sciences executive and healthcare investor, Vanessa…
📢 Today, in addition to announcing Stuart Hughes as our new CEO, we're also welcoming life sciences executive and healthcare investor, Vanessa…
Liked by Miquel Vila-Perello
-
Today, on National Doctors’ Day, we celebrate the incredible doctors on our team who help drive global progress in sight-saving research. Their…
Today, on National Doctors’ Day, we celebrate the incredible doctors on our team who help drive global progress in sight-saving research. Their…
Liked by Miquel Vila-Perello
-
Well that doesn’t feel like positive news. In my experience of dealing with OTP, and its previous incarnations, interactions with the division have…
Well that doesn’t feel like positive news. In my experience of dealing with OTP, and its previous incarnations, interactions with the division have…
Liked by Miquel Vila-Perello
-
Ahir vam donar la benvinguda a la primavera i el bon temps amb una nova edició dels nostres #PCBeers!🍺🌞🤝 Més de 100 membres de la #PCBCommunity…
Ahir vam donar la benvinguda a la primavera i el bon temps amb una nova edició dels nostres #PCBeers!🍺🌞🤝 Més de 100 membres de la #PCBCommunity…
Liked by Miquel Vila-Perello
-
Golden Gait Biotech will be attending Resi Conference @Life Science Nation @LSciNation in Barcelona next week. Happy to meet and see how we can…
Golden Gait Biotech will be attending Resi Conference @Life Science Nation @LSciNation in Barcelona next week. Happy to meet and see how we can…
Liked by Miquel Vila-Perello
-
The Foundation Fighting Blindness is in Tampa, FL discussing treatments and cures for inherited retinal disease and dry age-related macular…
The Foundation Fighting Blindness is in Tampa, FL discussing treatments and cures for inherited retinal disease and dry age-related macular…
Liked by Miquel Vila-Perello
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More